Bradley Chipps

Nov 4, 2024 | healio.com | Richard Gawel |Kristen Dowd |Bradley Chipps |Derek K. Chu

You've successfully added Asthma and Respiratory Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The meta-analysis included 27 unique randomized controlled trials and 50,496 patients.

Feb 3, 2023 | jacionline.org | Bradley Chipps |Alberto Papi |Frank Albers |Mark Cooper

Short-acting β -agonists (SABAs) treat symptoms, but not the underlying inflammation. A “window of opportunity” may exist to prevent severe exacerbations if symptoms and inflammation are treated concomitantly, as advocated by GINA and NAEPP.